The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
Growing evidence of Tranexamic Acid (TXA) being used to reduce blood loss and blood
transfusions in various guidelines. However, the adverse effects of TXA especially seizure
has always been a problem of concern, especially in neurosurgery. Therefore, this study aims
to provide a scientific evidence for the safety of TXA in supratentorial meningiomas
resection patients.